Ann: SMARTCOUGH-C Study and Paediatric Clinical Strategy Update, page-97

Argh... for freak's sake!  Didn't you people learn anything from round 1?!

In the space of five hours we've gone back to exactly the same kind of overblown, insane, dangerous, overconfident rhetoric that drew so many investors into ruinous over-exposure to this stock.

This is the second ever properly controlled, double-blind trial of the product in real-world conditions... and the first trial was an unmitigated failure.  Now we're trying again with mitigations in place, but aren't you at least a little bit more cautious the second time around?  Haven't you been made aware that the things you haven't thought of or dismissed as too unlikely will sink their fangs into your bum and tear off half your buttock?!

The pandas are weeping!!